Johannes W J Bijlsma, Johannes W G Jacobs. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Administration, OralAntirheumatic Agents/administration & dosageAntirheumatic Agents/adverse effectsAntirheumatic Agents/therapeutic useArthritis, Rheumatoid/drug therapyDose-Response Relationship, DrugDrug Monitoring/methodsDrug Monitoring/standardsEvidence-Based MedicineFatigue/chemically inducedHumansMethotrexate/administration & dosageMethotrexate/adverse effectsMethotrexate/therapeutic useNetherlandsTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances: See more » Antirheumatic AgentsTumor Necrosis Factor-alphaMethotrexate
Year: 2009 PMID: 19560956 DOI: 10.1016/j.jbspin.2009.05.007
Source DB: PubMed Journal: Joint Bone Spine ISSN: 1297-319X Impact factor: 4.929